Hinge Health (NYSE:HNGE) Now Covered by Analysts at Piper Sandler

Piper Sandler initiated coverage on shares of Hinge Health (NYSE:HNGE) in a report released on Monday morning, Marketbeat Ratings reports. The firm issued an overweight rating and a $41.00 price target on the stock.

A number of other research firms also recently commented on HNGE. Bank of America began coverage on shares of Hinge Health in a research note on Monday. They set a “buy” rating and a $42.00 price objective for the company. Evercore ISI began coverage on shares of Hinge Health in a research note on Monday. They set an “outperform” rating and a $50.00 price objective for the company. Barclays began coverage on shares of Hinge Health in a research note on Monday. They set an “overweight” rating and a $43.00 price objective for the company. KeyCorp assumed coverage on shares of Hinge Health in a research note on Monday. They set an “overweight” rating and a $45.00 price objective for the company. Finally, Needham & Company LLC assumed coverage on shares of Hinge Health in a research note on Monday. They issued a “buy” rating and a $47.00 target price for the company. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Hinge Health currently has an average rating of “Moderate Buy” and an average price target of $46.00.

Hinge Health Stock Up 5.2%

Hinge Health stock opened at $36.65 on Monday. Hinge Health has a one year low of $33.42 and a one year high of $43.80.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.